drugset / Trial / NCT06055361
A Study to Investigate the Safety, Tolerability, and Efficacy of BxC-I17e Single and Multiple Dose SC Injection in Patients With Moderate to Severe Atopic Dermatitis
RandomizedParallel-groupQuadruple-blindTreatment
Summary
The purpose of this study is to assess the safety, tolerability, and preliminary efficacy of a single and multiple SC dose of BxC-I17e in patients with moderate to severe atopic dermatitis (AD)
Timeline
- Start
- 2023-04-18
- Primary completion
- 2026-03-31
- Completion
- 2026-03-31
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | BxC-I17e | Other / unclassified | 25 ug | Subcutaneous |
| Subject | BxC-I17e | Other / unclassified | 50 ug | Subcutaneous |
| Subject | BxC-I17e | Other / unclassified | 100 ug | Subcutaneous |